Maxcyte (MXCT) executive compensation, 2026 proxy

Maher Masoud, President and Chief Executive Officer, was paid $2.7M in 2025, down 26% from $3.6M the year before.

Filed
April 29, 2026
Annual meeting
June 17, 2026
Pay year
2025
Named executives
3
CEO total pay
$2.7M-26% vs prior year
CEO pay in equity
66%$1.8M in awards
CEO Target Incentive
60%Percentage of annual base salary
Corporate Goals Achievement
88.5%For annual incentive compensation program

How Masoud was paid

$2.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary22%Stock awards43%Option awards23%Non-equity incentive12%All other compensation1%

Named executive officers

ExecutiveTotal
Maher MasoudPresident and Chief Executive Officer$2,687,657
Douglas SwirskyFormer Chief Financial Officer$1,225,057
Ali SoleymannezhadFormer Chief Commercial Officer$1,135,169

What changed and why

  • $2.7MMaher Masoud received total compensation of $2,687,657 in fiscal 2025, representing a decrease from his 2024 total.
  • 88.5%Annual performance bonuses were paid out at an 88.5% achievement level based on corporate goals.
  • Maher Masoud's 2025 equity awards were delivered entirely in options and performance-based restricted stock units.
  • Pearl Meyer served as the independent compensation consultant to evaluate executive pay programs.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.